These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17356340)

  • 1. Catatonia in obsessive-compulsive disorder: etiopathogenesis, differential diagnosis, and clinical management.
    Fontenelle LF; Lauterbach EC; Telles LL; Versiani M; Porto FH; Mendlowicz MV
    Cogn Behav Neurol; 2007 Mar; 20(1):21-4. PubMed ID: 17356340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
    Mukai Y; Two A; Jean-Baptiste M
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22687661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Catatonia due to Episodic Obsessive-Compulsive Disorder.
    Das S; Prasad S; Fichadia PA; Shrestha AB; Amuk Williams OC; Bachu A
    Case Rep Psychiatry; 2022; 2022():2022474. PubMed ID: 36425076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
    Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catatonia in pediatric obsessive-compulsive disorder: report of two cases.
    Jaimes-Albornoz W; Lee E; Serra-Mestres J; Isetta M; Ferrafiat V
    Eur Child Adolesc Psychiatry; 2022 Oct; 31(10):1645-1648. PubMed ID: 34091778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses].
    Sumitani S; Ueno S; Ishimoto Y; Taniguchi T; Tomotake M; Motoki I; Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(12):1282-92. PubMed ID: 17334085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
    Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
    Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturalistic course of obsessive compulsive disorder and comorbid depression. Longitudinal results of a prospective follow-up study of 74 actively treated patients.
    Zitterl W; Demal U; Aigner M; Lenz G; Urban C; Zapotoczky HG; Zitterl-Eglseer K
    Psychopathology; 2000; 33(2):75-80. PubMed ID: 10705250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of obsessive-compulsive disorder: a review for clinicians.
    McDonough M; Kennedy N
    Harv Rev Psychiatry; 2002; 10(3):127-37. PubMed ID: 12023928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study.
    Stryjer R; Dambinsky Y; Timinsky I; Green T; Kotler M; Weizman A; Spivak B
    Int Clin Psychopharmacol; 2013 Mar; 28(2):96-8. PubMed ID: 23211492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case Report of Scrupulosity Presenting as Catatonia in a Patient With Both OCD and OCPD.
    Nikjoo A; Wright C; Kheriaty A
    J Psychiatr Pract; 2022 May; 28(3):265-269. PubMed ID: 35511105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder.
    Husted DS; Shapira NA; Murphy TK; Mann GD; Ward HE; Goodman WK
    J Psychiatr Res; 2007; 41(3-4):332-7. PubMed ID: 16860338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study.
    Catapano F; Perris F; Masella M; Rossano F; Cigliano M; Magliano L; Maj M
    J Psychiatr Res; 2006 Sep; 40(6):502-10. PubMed ID: 16904424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.
    Poyurovsky M; Weizman A; Weizman R
    CNS Drugs; 2004; 18(14):989-1010. PubMed ID: 15584769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
    McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
    Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
    Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Pfanner C; Berloffa S; Pari C; Akiskal HS
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):475-86. PubMed ID: 17822342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
    Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
    J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive-compulsive disorder with poor insight: a three-year prospective study.
    Catapano F; Perris F; Fabrazzo M; Cioffi V; Giacco D; De Santis V; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):323-30. PubMed ID: 20015461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study.
    Bogan AM; Koran LM; Chuong HW; Vapnik T; Bystritsky A
    J Clin Psychiatry; 2005 Jan; 66(1):73-9. PubMed ID: 15669891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.